Cargando…

Circulating galectin-1 delineates response to bevacizumab in melanoma patients and reprograms endothelial cell biology

Blockade of vascular endothelial growth factor (VEGF) signaling with bevacizumab, a humanized anti-VEGF monoclonal antibody (mAb), or with receptor tyrosine kinase inhibitors, has improved progression-free survival and, in some indications, overall survival across several types of cancers by interru...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bannoud, Nadia, Stupirski, Juan C., Cagnoni, Alejandro J., Hockl, Pablo F., Pérez Sáez, Juan M., García, P. Alfredo, Mahmoud, Yamil D., Gambarte Tudela, Julián, Scheidegger, Marco A., Marshall, Andrea, Corrie, Pippa G., Middleton, Mark R., Mariño, Karina V., Girotti, M. Romina, Croci, Diego O., Rabinovich, Gabriel A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	National Academy of Sciences 2023
Materias:	Biological Sciences
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9934167/ https://www.ncbi.nlm.nih.gov/pubmed/36634146 http://dx.doi.org/10.1073/pnas.2214350120

Ejemplares similares

Circulating Galectin-1 and Galectin-3 in Sera From Patients With Systemic Sclerosis: Associations With Clinical Features and Treatment
por: Sundblad, Victoria, et al.
Publicado: (2021)

Galectin-1 expression imprints a neurovascular phenotype in proliferative retinopathies and delineates responses to anti-VEGF
por: Ridano, Magali E., et al.
Publicado: (2017)

Clinical Relevance of Galectin-1 and Galectin-3 in Rheumatoid Arthritis Patients: Differential Regulation and Correlation With Disease Activity
por: Mendez-Huergo, Santiago P., et al.
Publicado: (2019)

A Dynamic Interplay of Circulating Extracellular Vesicles and Galectin-1 Reprograms Viral Latency during HIV-1 Infection
por: Rubione, Julia, et al.
Publicado: (2022)

Turning-Off Signaling by Siglecs, Selectins, and Galectins: Chemical Inhibition of Glycan-Dependent Interactions in Cancer
por: Cagnoni, Alejandro J., et al.
Publicado: (2016)

Delineating the "galectin signature" of the tumor microenvironment
por: Compagno, Daniel, et al.
Publicado: (2013)

Sweetening the hallmarks of cancer: Galectins as multifunctional mediators of tumor progression
por: Girotti, María Romina, et al.
Publicado: (2019)

Galectin-1 Facilitates Macrophage Reprogramming and Resolution of Inflammation Through IFN-β
por: Yaseen, Hiba, et al.
Publicado: (2020)

Galectin-7 reprograms skin carcinogenesis by fostering innate immune evasive programs
por: Pinto, Nicolás A., et al.
Publicado: (2023)

Galectins in Intestinal Inflammation: Galectin-1 Expression Delineates Response to Treatment in Celiac Disease Patients
por: Sundblad, Victoria, et al.
Publicado: (2018)

Galectin-1 Prevents Infection and Damage Induced by Trypanosoma cruzi on Cardiac Cells
por: Benatar, Alejandro F., et al.
Publicado: (2015)

Immune Checkpoints Pathways in Head and Neck Squamous Cell Carcinoma
por: Veigas, Florencia, et al.
Publicado: (2021)

"Time sweet time": circadian characterization of galectin-1 null mice
por: Casiraghi, Leandro P, et al.
Publicado: (2010)

Control of Angiogenesis by Galectins Involves the Release of Platelet-Derived Proangiogenic Factors
por: Etulain, Julia, et al.
Publicado: (2014)

Endocytic Rabs Are Recruited to the Trypanosoma cruzi Parasitophorous Vacuole and Contribute to the Process of Infection in Non-professional Phagocytic Cells
por: Salassa, Betiana Nebaí, et al.
Publicado: (2020)

Disrupting galectin-1 interactions with N-glycans suppresses hypoxia-driven angiogenesis and tumorigenesis in Kaposi’s sarcoma
por: Croci, Diego O., et al.
Publicado: (2012)

Galectins as Emerging Glyco-Checkpoints and Therapeutic Targets in Glioblastoma
por: Videla-Richardson, Guillermo A., et al.
Publicado: (2021)

Galectin-1 as a potential cancer target
por: Rabinovich, G A
Publicado: (2005)

Akt/AS160 Signaling Pathway Inhibition Impairs Infection by Decreasing Rab14-Controlled Sphingolipids Delivery to Chlamydial Inclusions
por: Capmany, Anahí, et al.
Publicado: (2019)

Hypoxia Supports Differentiation of Terminally Exhausted CD8 T Cells
por: Bannoud, Nadia, et al.
Publicado: (2021)

25-hydroxyvitamin D serum levels in patients with high risk resected melanoma treated in an adjuvant bevacizumab trial
por: Lipplaa, Astrid, et al.
Publicado: (2018)

Thwarting galectin-induced immunosuppression in breast cancer
por: Salatino, Mariana, et al.
Publicado: (2013)

Galectin-1 is essential for efficient liver regeneration following hepatectomy
por: Potikha, Tamara, et al.
Publicado: (2016)

Galectin-1 Cooperates with Yersinia Outer Protein (Yop) P to Thwart Protective Immunity by Repressing Nitric Oxide Production
por: Jofre, Brenda Lucila, et al.
Publicado: (2021)

Tumor Necrosis Factor Receptor-1 (p55) Deficiency Attenuates Tumor Growth and Intratumoral Angiogenesis and Stimulates CD8(+) T Cell Function in Melanoma
por: Rodriguez, Yamila I., et al.
Publicado: (2020)

Control of intestinal inflammation by glycosylation-dependent lectin-driven immunoregulatory circuits
por: Morosi, Luciano G., et al.
Publicado: (2021)

“Galectin-1 Induces Central and Peripheral Cell Death: Implications in T-Cell Physiopathology”
por: Sotomayor, C. E., et al.
Publicado: (2000)

The universe of galectin-binding partners and their functions in health and disease
por: Troncoso, María F., et al.
Publicado: (2023)

EHRtemporalVariability: delineating temporal data-set shifts in electronic health records
por: Sáez, Carlos, et al.
Publicado: (2020)

Galectin-1 prevents pathological vascular remodeling in atherosclerosis and abdominal aortic aneurysm
por: Roldán-Montero, Raquel, et al.
Publicado: (2022)

Implementation of a molecular tumour board in LATAM: the impact on treatment decisions for patients evaluated at Instituto Alexander Fleming, Argentina
por: Angel, Martín Osvaldo, et al.
Publicado: (2021)

Systems-level effects of ectopic galectin-7 reconstitution in cervical cancer and its microenvironment
por: Higareda-Almaraz, Juan Carlos, et al.
Publicado: (2016)

Re-irradiation of recurrent IDH-wildtype glioblastoma in the bevacizumab and immunotherapy era: Target delineation, outcomes and patterns of recurrence
por: Christ, Sebastian M., et al.
Publicado: (2023)

Rab39a and Rab39b Display Different Intracellular Distribution and Function in Sphingolipids and Phospholipids Transport
por: Gambarte Tudela, Julián, et al.
Publicado: (2019)

Dual roles of endogenous and exogenous galectin-1 in the control of testicular immunopathology
por: Pérez, Cecilia V., et al.
Publicado: (2015)

Galectin-1 as an Emerging Mediator of Cardiovascular Inflammation: Mechanisms and Therapeutic Opportunities
por: Seropian, Ignacio M., et al.
Publicado: (2018)

Prognostic Value of the Interaction between Galectin-3 and Antigen Carbohydrate 125 in Acute Heart Failure
por: Núñez, Julio, et al.
Publicado: (2015)

Induction of Autophagy by Ursolic Acid Promotes the Elimination of Trypanosoma cruzi Amastigotes From Macrophages and Cardiac Cells
por: Vanrell, María Cristina, et al.
Publicado: (2022)

A randomised trial evaluating bevacizumab as adjuvant therapy following resection of AJCC stage IIB, IIC and III cutaneous melanoma: an update
por: Biswas, S, et al.
Publicado: (2008)

Linking tumor hypoxia with VEGFR2 signaling and compensatory angiogenesis: Glycans make the difference
por: Croci, Diego O, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_c6krdsq3hmt8ojm96jlpvst8c2